Home
Healthcare
Healthcare & Pharmaceuticals
Comparator Drug Sourcing Market Size, Share & Growth [2030]

Comparator Drug Sourcing Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - By End-user (Drug Producers/Manufacturers, CMO, Academic and Research Institute), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030

HC-5063
4.7 Rating
164 Pages

16-02-2023
65 Reviews

Author:

Raksha Sharma

Fact-checked by:

Vineet Pandey

Editor:

Shreyas Tandon

Report Description

Comparator Drug Sourcing Market Outlook

The global comparator drug sourcing market size was valued at USD 941.0 Million in 2021 and is projected to reach USD 1,267.0 Million by 2030, expanding at a CAGR of 3.5% during the forecast period, 2022-2030.

Comparator drug sourcing is a sourcing approach whereby the comparator product is accepted within a single country and used in a clinical trial inside the same country. The product evades charges on import and export and regulations, which is considered to speed up the clinical trial supply chain and is cost-effective.

Macro-economic Factors

Government authorities are concerned about the health and safety of citizens and healthcare workers, hence they issued various safety guidelines and regulations. Governments of several countries released guidelines regarding precautions and the use of drugs.

Increasing number of strategies such as mergers & acquisitions, agreements, partnerships, and product launches among companies to establish themselves as providers of Comparator Drug Sourcing are anticipated to create lucrative opportunities in the market in the near future. Rising adoption of various strategies by market players to increase their presence and share in the market is expected to create growth opportunities in the market.

Comparator Drug Sourcing Market Dynamics

Rising chronic diseases

Increasing prevalence of various chronic diseases such as cardiac, neurological, and cancer is anticipated to boost the market during the forecast period. Rising cases of cancer and cardiovascular diseases are projected to increase the demand for drugs, resulting in high market growth.

Many infections caused by certain bacteria and viruses require treatment and support for the recovery of nutrients and water balance in the blood. Healthcare providers prescribe supplements or generic drugs for the disease if the precise medicines are not available in the market. This factor drives the market.

Strict Government Policies

Various policies and regulations implemented by governments in various nations throughout the world regulating the production of drugs are expected to have a significant effect on market growth and pricing.

The invention of the drug requires years to be discovered and launched into the market. The procedure needs huge investments along with clinical trials. Increasing demand for drug repurposing requires study and research on available drugs.

The market in Asia Pacific holds a substantial share of the global drug repurposing market, due to a rapid increase in research and development activities. Low research costs and easy bioavailability are anticipated to propel the market around the globe.

Development of drugs for bacterial infections

Bacterial infections are considered a major threat to the human population, as it is expected to be a leading cause of death in the near future. The new uses of old drugs are considered to create lucrative opportunities. Players are focusing on and adopting strategies of research and study of the formula used in old drugs and its reaction with the bacteria.

For instance, the Phenothiazine prototype, Methdilazine, was initially used to treat skin allergies and is now used for treating anti-bacterial agents. Rising use of old drugs and the invention of new drugs is expected to drive the market during the forecast period.

Scope of Comparator Drug Sourcing Market Report

The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Comparator Drug Sourcing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
Base Year	2021
Historic Data	2015–2020
Forecast Period	2022–2030
Segmentation	End-user (Drug Producers/Manufacturers, CMO, Academic and Research Institute, Others)
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Report Coverage	Company Share, Comparator Drug Sourcing Market Size and Analysis, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered	AmerisourceBergen Corporation; Avantor, Inc.; Clinical Services International (CSI); Clinigen Clinical Supplies Management; Intertek Group plc; MCKESSON CORPORATION; Myonex; PHARMA’S ALMANAC; Sharp Services, LLC; Thermo Fisher Scientific; and TransCelerate BioPharma Inc.

Comparator Drug Sourcing Market Segment Insights

Based on end-user, the global Comparator Drug Sourcing market is segmented into drug producers/manufacturers, CMO, academic and research institute, and others. The drug producers/ manufacturers segment held a significant share of the market in 2021. Moreover, the academic and research institute segment is expected to grow rapidly.

Comparator Drug Sourcing Market Regional Outlook

Based on region, the global Comparator Drug Sourcing market share is segmented as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold a substantial share of the market, owing to technological advancements in the region. The market in Asia Pacific is expected to grow at a rapid pace.

Segments

End-user

Drug Producers/Manufacturers
CMO
Academic and Research Institute
Others

Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Key Players

AmerisourceBergen Corporation
Avantor, Inc.
Clinical Services International (CSI)
Clinigen Clinical Supplies Management
Intertek Group plc
MCKESSON CORPORATION
Myonex
PHARMA’S ALMANAC
Sharp Services, LLC
Thermo Fisher Scientific
TransCelerate BioPharma Inc.

Competitive Landscape

Key players competing in the global comparator drug sourcing market are AmerisourceBergen Corporation; Avantor, Inc.; Clinical Services International (CSI); Clinigen Clinical Supplies Management; Intertek Group plc; MCKESSON CORPORATION; Myonex; PHARMA’S ALMANAC; Sharp Services, LLC; Thermo Fisher Scientific; and TransCelerate BioPharma Inc.

These key players adopt various strategies including mergers, acquisitions, collaboration, partnerships, product launches, and production expansion to expand their consumer base globally.

On September 29, 2022, Myonex launched the first and only on-demand local drug sourcing in Europe. CTRx Europe offers significant benefits for trial sponsors, patients, and sites alike, built on a successful North American program. The new CTRx Europe solution is a game-changer for clinical sites in Europe and it offers support for sites to source local drugs for local patients in individual European countries.

On June 14, 2021, Thermo Fisher Scientific introduced a new Quick to Clinic solution to help biologic drug developers accelerate preclinical development at BIO Digital 2021. The enhanced Quick to Clinic solution helps biopharma companies to reach Phase 1/First-In-Human trials and file for Investigation New Drug (IND) review in as little as 13 months from transfection.

Table Of Content

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Comparator Drug Sourcing Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Comparator Drug Sourcing Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Comparator Drug Sourcing Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Comparator Drug Sourcing Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Comparator Drug Sourcing Market Size & Forecast, 2015-2030
      4.5.1 Comparator Drug Sourcing Market Size and Y-o-Y Growth
      4.5.2 Comparator Drug Sourcing Market Absolute $ Opportunity
   4.6 Regulations and Standards
Chapter 5 Global Comparator Drug Sourcing Market Analysis and Forecast By End-User
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By End-User
      5.1.2 Basis Point Share (BPS) Analysis By End-User
      5.1.3 Absolute $ Opportunity Assessment By End-User
   5.2 Comparator Drug Sourcing Market Size Forecast By End-User
      5.2.1 Drug Producers/Manufacturers
      5.2.2 CMO
      5.2.3 Academic and Research Institute
   5.3 Market Attractiveness Analysis By End-User
Chapter 6 Global Comparator Drug Sourcing Market Analysis and Forecast by Region
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Region
      6.1.2 Basis Point Share (BPS) Analysis by Region
      6.1.3 Absolute $ Opportunity Assessment by Region
   6.2 Comparator Drug Sourcing Market Size Forecast by Region
      6.2.1 North America
      6.2.2 Europe
      6.2.3 Asia Pacific
      6.2.4 Latin America
      6.2.5 Middle East & Africa (MEA)
   6.3 Market Attractiveness Analysis by Region
Chapter 7 Coronavirus Disease (COVID-19) Impact
   7.1 Introduction
   7.2 Current & Future Impact Analysis
   7.3 Economic Impact Analysis
   7.4 Government Policies
   7.5 Investment Scenario
Chapter 8 North America Comparator Drug Sourcing Analysis and Forecast
   8.1 Introduction
   8.2 North America Comparator Drug Sourcing Market Size Forecast by Country
      8.2.1 U.S.
      8.2.2 Canada
   8.3 Basis Point Share (BPS) Analysis by Country
   8.4 Absolute $ Opportunity Assessment by Country
   8.5 Market Attractiveness Analysis by Country
   8.6 North America Comparator Drug Sourcing Market Size Forecast By End-User
      8.6.1 Drug Producers/Manufacturers
      8.6.2 CMO
      8.6.3 Academic and Research Institute
   8.7 Basis Point Share (BPS) Analysis By End-User
   8.8 Absolute $ Opportunity Assessment By End-User
   8.9 Market Attractiveness Analysis By End-User
Chapter 9 Europe Comparator Drug Sourcing Analysis and Forecast
   9.1 Introduction
   9.2 Europe Comparator Drug Sourcing Market Size Forecast by Country
      9.2.1 Germany
      9.2.2 France
      9.2.3 Italy
      9.2.4 U.K.
      9.2.5 Spain
      9.2.6 Russia
      9.2.7 Rest of Europe
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 Europe Comparator Drug Sourcing Market Size Forecast By End-User
      9.6.1 Drug Producers/Manufacturers
      9.6.2 CMO
    9.6.3 Academic and Research Institute
   9.7 Basis Point Share (BPS) Analysis By End-User
   9.8 Absolute $ Opportunity Assessment By End-User
   9.9 Market Attractiveness Analysis By End-User
Chapter 10 Asia Pacific Comparator Drug Sourcing Analysis and Forecast
   10.1 Introduction
   10.2 Asia Pacific Comparator Drug Sourcing Market Size Forecast by Country
      10.2.1 China
      10.2.2 Japan
      10.2.3 South Korea
      10.2.4 India
      10.2.5 Australia
      10.2.6 South East Asia (SEA)
    10.2.7 Rest of Asia Pacific (APAC)
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Asia Pacific Comparator Drug Sourcing Market Size Forecast By End-User
      10.6.1 Drug Producers/Manufacturers
      10.6.2 CMO
      10.6.3 Academic and Research Institute
   10.7 Basis Point Share (BPS) Analysis By End-User
   10.8 Absolute $ Opportunity Assessment By End-User
   10.9 Market Attractiveness Analysis By End-User
Chapter 11 Latin America Comparator Drug Sourcing Analysis and Forecast
   11.1 Introduction
   11.2 Latin America Comparator Drug Sourcing Market Size Forecast by Country
      11.2.1 Brazil
      11.2.2 Mexico
      11.2.3 Rest of Latin America (LATAM)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Latin America Comparator Drug Sourcing Market Size Forecast By End-User
      11.6.1 Drug Producers/Manufacturers
      11.6.2 CMO
      11.6.3 Academic and Research Institute
   11.7 Basis Point Share (BPS) Analysis By End-User
   11.8 Absolute $ Opportunity Assessment By End-User
   11.9 Market Attractiveness Analysis By End-User
Chapter 12 Middle East & Africa (MEA) Comparator Drug Sourcing Analysis and Forecast
   12.1 Introduction
   12.2 Middle East & Africa (MEA) Comparator Drug Sourcing Market Size Forecast by Country
      12.2.1 Saudi Arabia
      12.2.2 South Africa
      12.2.3 UAE
      12.2.4 Rest of Middle East & Africa (MEA)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Middle East & Africa (MEA) Comparator Drug Sourcing Market Size Forecast By End-User
      12.6.1 Drug Producers/Manufacturers
      12.6.2 CMO
      12.6.3 Academic and Research Institute
   12.7 Basis Point Share (BPS) Analysis By End-User
   12.8 Absolute $ Opportunity Assessment By End-User
   12.9 Market Attractiveness Analysis By End-User
Chapter 13 Competition Landscape
   13.1 Comparator Drug Sourcing Market: Competitive Dashboard
   13.2 Global Comparator Drug Sourcing Market: Market Share Analysis, 2021
   13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      13.3.1 AmerisourceBergen Corporation
      13.3.2 Avantor, Inc.
      13.3.3 Clinical Services International (CSI)
      13.3.4 Clinigen Clinical Supplies Management
      13.3.5 Intertek Group plc
      13.3.6 MCKESSON CORPORATION
      13.3.7 Myonex
      13.3.8 PHARMA’S ALMANAC
      13.3.9 Sharp Services, LLC
      13.3.10 Thermo Fisher Scientific
      13.3.11 TransCelerate BioPharma Inc.

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked quetions about this report!

1. Which is the base year calculated in the global Comparator Drug Sourcing market report and what is analysis period?

The base year considered for the global Comparator Drug Sourcing market report is 2021. The complete analysis period is 2015 to 2030, wherein, 2015-2020 are the historic years, and the forecast is provided from 2022 to 2030.

2. What additional data analysis is available in report?

In addition to market size (in US$ Million), Company Market Share (in % for base year 2021), and regulatory landscape.

3. What is the impact of COVID-19 on the overall market during year 2019 -2020?

The market is expected to slightly increase in 2019 and 2020 owing to the research and development activities in regard to COVID 19 pandemic on the Comparator Drug Sourcing market.

4. Who are the major players operating in the market?

Major manufacturers include, AmerisourceBergen Corporation, Avantor, Inc., Clinical Services International (CSI), Clinigen Clinical Supplies Management, Intertek Group plc, MCKESSON CORPORATION, Myonex, PHARMA’S ALMANAC, Sharp Services, LLC, Thermo Fisher Scientific, TransCelerate BioPharma Inc. and others.